Serum lipoprotein(a) level in relation to severity of coronary artery disease and coronary artery patency in acute myocardial infarction

Heart and Vessels

Volumn 16, Issue 2, 2002, Pages 37-41

  Uusimaa, P ^a   Kervinen, Kari ^a   Kesäniemi, Antero ^a   Peuhkurinen, Keijo ^b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Coronary angiography; Coronary artery disease; Lipoprotein(a); Myocardial infarction

Indexed keywords

CREATINE KINASE MB; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; MYOGLOBIN;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROGENESIS; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; DRESSLER SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE REPERFUSION; HOSPITALIZATION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RESTENOSIS; RISK ASSESSMENT; SCORING SYSTEM; THROMBOSIS;

BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MYOCARDIAL INFARCTION; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0036156266     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s380-002-8314-4     Document Type: Article

References (29)

1. The role of lipoprotein(a) in atherogenesis and thrombosis
2. Lp(a) lipoprotein as a risk factor for myocardial infarction
3. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study
4. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies
5. A prospective study of lipoprotein(a) and the risk of myocardial infarction
6. Lipoprotein(a) is not associated with coronary artery disease in the elderly: Cross-sectional data from the Dubbo study
7. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography
8. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography
9. Relation of coronary artery disease in women <60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio
10. Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis
11. Serum lipoprotein(a) concentrations are related to coronary disease progression without new myocardial infarction
12. Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a)
13. Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women
14. Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectoris
15. Correlation between serum lipoprotein(a) and angiographic coronary artery disease in non-insulin-dependent diabetes mellitus
16. Correlation of serum lipoprotein(a) with the angiographic and clinical presentation of coronary artery disease
17. Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty
18. Lipoprotein(a) level does not predict restenosis after percutaneous transluminal coronary angioplasty
19. Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction
20. Lack of association between raised serum Lp(a) concentration and unsuccesful thrombolysis after acute myocardial infarction
21. Effects of lipoprotein(a) on success rate of thrombolytic therapy in acute myocardial infarction
22. Lipoprotein(a) levels in patients with myocardial infarction treated with anistreplase: No prediction of efficacy but inverse correlation with plasminogen activation in non-patency
23. Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction
24. Serum lipoprotein(a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction
25. Non-invasive assessment of infarct reperfusion: The predictive power of the time to peak value of myoglobin, CKMB and CK in serum
26. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves of early assessment of coronary artery reperfusion after intravenous thrombolysis
27. The Thrombolysis In Myocardial Infarction (TIMI) trial. Phase 1 findings
28. Severity of coronary artery disease
29. Thrombolysis with tissue plasminogen activator enhances serum lipoprotein(a) levels compared to streptokinase and conservative treatment in patients with acute myocardial infarction